Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Asan Medical Center
Centre Oscar Lambret
Centre Oscar Lambret
Ankara University
Incheon St.Mary's Hospital
Shanghai Cancer Hospital, China
Delfi Diagnostics Inc.
University of Kentucky
UNICANCER
Cook Group Incorporated
Regeneron Pharmaceuticals
Karolinska University Hospital
University of Iowa
Erasmus Medical Center
Abramson Cancer Center at Penn Medicine
AstraZeneca
Wake Forest University Health Sciences
University of Pennsylvania
Grupo Espanol de Tumores Neuroendocrinos
Columbia University
Hoffmann-La Roche
Immuneering Corporation
Memorial Sloan Kettering Cancer Center